TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution-Reference-Cited by-同舟云学术

TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution

Published:2015-07 Issue:7 Volume:5 Page:e331-e331
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer Journal

Author:

Hou H-A,Chou W-C,Kuo Y-Y,Liu C-Y,Lin L-I,Tseng M-H,Chiang Y-C,Liu M-C,Liu C-W,Tang J-L,Yao M,Li C-C,Huang S-Y,Ko B-S,Hsu S-C,Chen C-Y,Lin C-T,Wu S-J,Tsay W,Chen Y-C,Tien H-F

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://www.nature.com/articles/bcj201559.pdf

Reference35 articles.

1. Isobe M, Emanuel BS, Givol D, Oren M, Croce CM . Localization of gene for human p53 tumour antigen to band 17p13. Nature 1986; 320: 84–85.

2. Hollstein M, Sidransky D, Vogelstein B, Harris CC . p53 mutations in human cancers. Science 1991; 253: 49–53.

3. Petitjean A, Achatz MI, Borresen-Dale AL, Hainaut P, Olivier M . TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene 2007; 26: 2157–2165.

4. Vogelstein B, Lane D, Levine AJ . Surfing the p53 network. Nature 2000; 408: 307–310.

5. Olivier M, Petitjean A, Marcel V, Petre A, Mounawar M, Plymoth A et al. Recent advances in p53 research: an interdisciplinary perspective. Cancer Gene Ther 2009; 16: 1–12.

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytogenetics and genomics of acute myeloid leukemia;Best Practice & Research Clinical Haematology;2024-03

2. An Ensemble Model for Acute Myeloid Leukemia Risk Stratification Recommendations by Combining Machine Learning with Clinical Guidelines;2024-01-09

3. Acute myeloid leukemia patients with high-risk karyotypes benefit from decitabine in combination with modified CAG;2024-01-08

4. Decitabine combined with low-dose cytarabine, aclarubicin and rhG-CSF regimen may be a potential alternative for relapsed/refractory acute myeloid leukemia: A single-center study;memo - Magazine of European Medical Oncology;2023-11-20

5. Ring Chromosomes in Hematological Malignancies Are Associated with TP53 Gene Mutations and Characteristic Copy Number Variants;Cancers;2023-11-16